Raised bumps on the skin can appear for various reasons, ranging from harmless conditions to more serious medical concerns.

Australia's Therapeutic Goods Administration has an ongoing investigation into a key ingredient of ArmaForce, which is ...

Immediately, Trump's new Health appointees were met with a rash of strong reactions from assorted media outlets.

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...

During her meeting with President Erdoğan, Ursula von der Leyen announced an additional €1 billion to support Syrian refugees ...

L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.